Canada Life’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,508
| Closed | -$15K | – | 2080 |
|
|
2024
Q2 | $15K | Hold |
3,508
| – | – | ﹤0.01% | 2066 |
|
|
2024
Q1 | $52K | Buy |
+3,508
| New | +$53K | ﹤0.01% | 2011 |
|
|
2022
Q4 | – | Sell |
-16,919
| Closed | -$59K | – | 2370 |
|
|
2022
Q3 | $59K | Buy |
16,919
+13,824
| +447% | +$52.9K | ﹤0.01% | 2069 |
|
|
2022
Q2 | $9K | Buy |
3,095
+207
| +7% | +$1.09K | ﹤0.01% | 2376 |
|
|
2022
Q1 | $27K | Buy |
2,888
+213
| +8% | +$2.35K | ﹤0.01% | 2298 |
|
|
2021
Q4 | $43K | Buy |
2,675
+201
| +8% | +$3.78K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $52K | Hold |
2,474
| – | – | ﹤0.01% | 2227 |
|
|
2021
Q2 | $66K | Sell |
2,474
-789
| -24% | -$23.1K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $103K | Hold |
3,263
| – | – | ﹤0.01% | 2094 |
|
|
2020
Q4 | $74K | Hold |
3,263
| – | – | ﹤0.01% | 2175 |
|
|
2020
Q3 | $82K | Hold |
3,263
| – | – | ﹤0.01% | 2077 |
|
|
2020
Q2 | $90K | Hold |
3,263
| – | – | ﹤0.01% | 2069 |
|
|
2020
Q1 | $19K | Hold |
3,263
| – | – | ﹤0.01% | 2382 |
|
|
2019
Q4 | $35K | Buy |
+3,263
| New | +$32.3K | ﹤0.01% | 2381 |
|
|
2019
Q3 | – | Sell |
-6,215
| Closed | -$105K | – | 1793 |
|
|
2019
Q2 | $105K | Hold |
6,215
| – | – | ﹤0.01% | 2214 |
|
|
2019
Q1 | $111K | Hold |
6,215
| – | – | ﹤0.01% | 2041 |
|
|
2018
Q4 | $76K | Buy |
6,215
+3,715
| +149% | +$62.3K | ﹤0.01% | 2237 |
|
|
2018
Q3 | $54K | Hold |
2,500
| – | – | ﹤0.01% | 2374 |
|
|
2018
Q2 | $52K | Hold |
2,500
| – | – | ﹤0.01% | 2394 |
|
|
2018
Q1 | $63K | Hold |
2,500
| – | – | ﹤0.01% | 2308 |
|
|
2017
Q4 | $47K | Hold |
2,500
| – | – | ﹤0.01% | 2376 |
|
|
2017
Q3 | $46K | Hold |
2,500
| – | – | ﹤0.01% | 2355 |
|
|
2017
Q2 | $44K | Hold |
2,500
| – | – | ﹤0.01% | 2361 |
|
|
2017
Q1 | $46K | Hold |
2,500
| – | – | ﹤0.01% | 2324 |
|
|
2016
Q4 | $51K | Hold |
2,500
| – | – | ﹤0.01% | 2320 |
|
|
2016
Q3 | $75K | Hold |
2,500
| – | – | ﹤0.01% | 2245 |
|
|
2016
Q2 | $67K | Hold |
2,500
| – | – | ﹤0.01% | 2236 |
|
|
2016
Q1 | $47K | Hold |
2,500
| – | – | ﹤0.01% | 2157 |
|
|
2015
Q4 | $77K | Hold |
2,500
| – | – | ﹤0.01% | 1930 |
|
|
2015
Q3 | $54K | Hold |
2,500
| – | – | ﹤0.01% | 2059 |
|
|
2015
Q2 | $95K | Hold |
2,500
| – | – | ﹤0.01% | 1906 |
|
|
2015
Q1 | $78K | Buy |
+2,500
| New | +$84.7K | ﹤0.01% | 1934 |
|
Other funds holding MGNX
BG
AC
FLSM
WA
PA
Canada Life's MGNX Position: Q3 2024 in Review
Canada Life sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 3,508 shares — an estimated $15K sold.
Canada Life first reported a position in MGNX in Q1 2015 and held it in 32 quarters. The position peaked at $111K in Q1 2019. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.
- Canada Life reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
- Canada Life sold 3,508 MacroGenics shares in Q3 2024, an estimated $15K.
- Canada Life first reported a position in MacroGenics in Q1 2015 and held it in 32 quarters.
- Canada Life's MacroGenics position peaked at $111K in Q1 2019.
- 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.
Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.